Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 7:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1249–1272 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Melanoma
Interventions: MelaFind(R); Device
Lead sponsor: MELA Sciences, Inc.; Industry
Eligibility: Not listed
Enrollment: 1,383 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Plantation, Florida • Tallahassee, Florida

Conditions: Brain Metastases, Adult, Neurocognitive Function, Cancer, Meningioma of Brain, Arteriovenous Malformations, Cerebral
Interventions: Cognitive Sparing Brain Stereotactic Radiosurgery (SRS); Radiation
Lead sponsor: Jona Hattangadi-Gluth; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: San Diego, California

Conditions: Parkinson's Disease Dementia
Interventions: Rivastigmine capsule, Rivastigmine transdermal patch; Drug
Lead sponsor: Novartis; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 583 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 17
States / cities: Birmingham, Alabama • Phoenix, Arizona • Reseda, California + 14 more

Conditions: Breast Lesions
Interventions: Intact Breast Lesion Excision System (BLES); Device
Lead sponsor: Medtronic Surgical Technologies; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 7
States / cities: Birmingham, Alabama • Atlanta, Georgia • Dalton, Georgia + 4 more

Conditions: Skin Lesion
Interventions: Ultrasound; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Migraine Disorders
Interventions: NP101; Drug
Lead sponsor: NuPathe Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 514 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 31
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Irvine, California + 28 more

Conditions: Smoking Cessation
Interventions: UP-ST Therapy, Standard Therapy, Nicotine Patch; Behavioral · Device
Lead sponsor: University of Houston; Other
Eligibility: 18 Years to 65 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Smoking Cessation, Schizophrenia
Interventions: Combination Bupropion + NRTs, Extended Treatment, Home Visits & Calls, Monotherapy; Drug · Other
Lead sponsor: Brentwood Biomedical Research Institute; Other
Eligibility: 21 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Smoking, Nicotine Dependence, Mental Disorders
Interventions: Cognitive / Motivational Individual Sessions, Attention Control Individual Sessions, Nicotine Patch, Group Curriculum; Behavioral · Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 99 Years
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Persistent Atrial Fibrillation
Interventions: The Estech COBRA® Surgical System; Device
Lead sponsor: Endoscopic Technologies, Inc; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 13
States / cities: Mesa, Arizona • Hartford, Connecticut • Atlanta, Georgia + 10 more

Conditions: Knee Injuries, Joint Surface Knee Lesions
Interventions: Marketed Product - MP01, Surgical Standard of Care; Device · Procedure
Lead sponsor: Smith & Nephew, Inc.; Industry
Eligibility: 21 Years to 75 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: La Mesa, California

Conditions: Cystic Fibrosis, Hypoestrogenism
Interventions: Transdermal estrogen, Progesterone; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 0 Years to 100 Years · Female only
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chemo Brain, Chemotherapy-related Cognitive Impairment, Chemo Fog, Breast Cancer, Chemobrain
Interventions: Transdermal nicotine, Placebo Transdermal Patch; Drug · Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 35 Years to 80 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Ankle Sprain
Interventions: FS-67 Patch, Placebo Patch; Drug · Other
Lead sponsor: Hisamitsu Pharmaceutical Co., Inc.; Industry
Eligibility: 13 Years to 17 Years
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 23
States / cities: Birmingham, Alabama • Tucson, Arizona • Hot Springs, Arkansas + 19 more

Conditions: Primary Open Angle Glaucoma, Primary Angle Closure Glaucoma, Pseudoexfoliation Glaucoma, Pigmentary Glaucoma, Traumatic Glaucoma, Uveitic Glaucoma, Neovascular Glaucoma
Interventions: Molteno 3 glaucoma drainage shunt; Procedure
Lead sponsor: Wills Eye; Other
Eligibility: 19 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Atrial Fibrillation
Interventions: iRhythm ZIO XT Patch, Wristband by Amiigo; Device
Lead sponsor: Scripps Translational Science Institute; Other
Eligibility: 55 Years and older
Enrollment: 6,135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Light Sensitivity
Interventions: eye covers; Behavioral
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: Not listed
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Liver Cancer, Neoplasms, Liver, Hepatic Neoplasms, Hepatic Cancer
Interventions: CT/CBCT thermometry method, Ablation Probe; Procedure
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Smoking Cessation, Tobacco Use Cessation, Tobacco Smoking
Interventions: Nicorette, Tobacco Quit-line, Brief Behavioral Counseling, Intensive Behavioral Counseling; Drug · Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 608 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Atopic Dermatitis Eczema
Interventions: Investigational OTC Cream, 0.05% Desonide, Placebo Cream; Drug · Other
Lead sponsor: Procter and Gamble; Industry
Eligibility: 12 Years to 65 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Raleigh, North Carolina • Chattanooga, Tennessee

Conditions: Smoking Cessation
Interventions: Empowerment activity-enhanced tobacco cessation assistance; Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Chalazion
Interventions: SUN-131 1.5% TDS, Placebo TDS; Drug
Lead sponsor: Senju USA, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 6
States / cities: Santa Ana, California • Littleton, Colorado • Washington D.C., District of Columbia + 3 more

Conditions: Pain Associated With Epidural Needle Insertion
Interventions: Synera(TM), Placebo patch; Drug · Other
Lead sponsor: IWK Health Centre; Other
Eligibility: 18 Years and older · Female only
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Benign Pigmented Lesions
Interventions: LaseMD and DUAL 1927nm Laser, LaseMD; Device
Lead sponsor: CynosureLutronic; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Hunt Valley, Maryland • Charlotte, North Carolina

Search by objective public record fields.

Evaluation of Pigmented Skin Lesions With MelaFind(R) System

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions

Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)

A Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES)

Ultrasound in Diagnosing Patients With Skin Lesions

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

Adaptation and Initial Evaluation of Transdiagnostic CBT for Anxious and Depressed Smokers

Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment

Helping Those With Mental Illness Quit Smoking

Efficacy and Safety Study of the Estech COBRA® Surgical System to Treat Patients With a History of Irregular Heart Beats

A Post Approval Multicenter 10 Year Follow-up Observational Trial of Marketed Product - MP01 vs. Surgical Standard of Care (SSOC) Used for the Treatment of Joint Surface Lesions of the Knee

Estrogen Supplementation and Bone Health in Women With CF

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

FS-67 in the Treatment of Pediatric Patients With Ankle Sprain

Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube

mHealth Screening to Prevent Strokes

"Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores"

Study of New Software Used During Ablations

Smoking Cessation Program in the Construction Sector

8-Week Atopic Dermatitis (AD) Treatment Study

Empowering LGBTQ+ Tobacco Cessation Pilot

Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion

Synera™ for Epidural Needle Insertion

Lutronic LaseMD for Treatment of Benign Pigmented Lesions